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Conclusion
Both the absolute amount of protein and the activity per gram liver shows an
increase with age, suggesting growth and maturation of the CYP450
isoenzymes. This maturation of the CYP450 isoenzymes is also observed in
human, suggesting the piglet might be a suitable animal model for preclinical
PK/PD research.
Results
0
100
200
300
400
500
600
0 5 10 15 20 25 30
1
-H
y
d
ro
x
y
-m
id
a
z
o
la
m
 f
o
rm
a
ti
o
n
 (
p
m
o
l/
m
in
/g
 l
iv
e
r)
age (weeks)
BIOTRANSFORMATION RATE OF 
MIDAZOLAM
median median male median female male female
0
100
200
300
400
500
600
700
800
900
1000
0 5 10 15 20 25 30
4
-H
y
d
ro
x
y
-t
o
lb
u
ta
m
id
e
 f
o
rm
a
ti
o
n
 (
p
m
o
l/
m
in
/g
 l
iv
e
r)
age (weeks)
BIOTRANSFORMATION RATE OF 
TOLBUTAMIDE
median median male median female male female
0
1
2
3
4
5
6
7
8
0 5 10 15 20 25 30
6
-H
y
d
ro
x
y
-c
h
lo
rz
o
x
a
z
o
n
e
 f
o
rm
a
ti
o
n
(n
m
o
l/
m
in
/g
 
liv
e
r)
age (weeks)
BIOTRANSFOMATION RATE OF 
CHLORZOXAZONE
median median male median female male female
Objectives and methods
Development of appropriate animal models taking growth and maturation into account is pivotal for pediatric preclinical pharmacokinetic and pharmacodynamic (PK/PD) research. Literature
reports have demonstrated a high homology between human and porcine CYP450 enzymes in adults, suggesting the pig as a suited animal model for PK/PD and safety studies (1, 2).
However data regarding the ontogeny of porcine hepatic CYP enzymes are lacking. The aim of this research was to gain more insight in the development of the CYP450 enzymes by in vitro
enzyme activity experiments and through proteomics.
The in vitro CYP450 enzyme activity of the following probe substrates was measured in microsomes: midazolam (CYP3A), tolbutamide (CYP2C) and chlorzoxazone (CYP2E). The
microsomes were prepared of each time 16 pigs (8 ♂ and 8 ♀, Hybrid sow x Piétrain boar) aging 2 days, 4 weeks, 8 weeks and 6-7 months. The corresponding metabolites were quantified
using a validated UHPLC-MS/MS method (3). Furthermore, the microsomal protein per gram liver (MPPGL) was determined (4). In addition to these in vitro activity experiments, the CYP
isoenzymes in the same microsomes were determined by high definition data directed analysis (HD-DDA) mass spectrometry. The data analysis was performed using Progenesis QI.
A total of 20 CYP isoenzymes were identified of which 12 had 2 or more unique peptides. A pig liver pie out of the average amount of protein for the 6 and 7 months old pigs was
calculated. This was considered to be 100% to recalculate the proportion of the younger age categories as shown above. At puberty significant sex differences (P < 0,05) were
observed.
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The microsomal activity of the three substrates, expressed as pmol metabolite formed per minute and per milligram microsomal protein, increased with age. Significant sex
differences were observed at 8 weeks of age for the three substrates and at 6 months of age for chlorzoxazone (P < 0,05 ; data not shown). The activity per gram liver, as
calculated with the MPPGL and shown above, also showed a maturation profile. However the sex differences are no longer statistically significant. The increase in microsomal
activity is reflected in an increase in CYP450 proteins in the microsomes.
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